0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Molecular Exploitation Of Apoptosis Pathways In Prostate Cancer (Hardcover, New) Loot Price: R2,612
Discovery Miles 26 120
Molecular Exploitation Of Apoptosis Pathways In Prostate Cancer (Hardcover, New): Natasha Kyprianou

Molecular Exploitation Of Apoptosis Pathways In Prostate Cancer (Hardcover, New)

Natasha Kyprianou

Series: Molecular Medicine And Medicinal Chemistry, 5

 (sign in to rate)
Loot Price R2,612 Discovery Miles 26 120 | Repayment Terms: R245 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

This book focuses on the functional significance of targeting apoptosis for the treatment of prostate cancer. New concepts on the challenges relating to the development of resistance by androgen-independent tumors are introduced, in terms of the contribution of anoikis and cross-talk of androgens with key growth factor signaling pathways. This volume also provides insightful discussion on the exploitation of the apoptotic and angiogenic synergism towards complete eradication of prostate tumors. Last but not least, it includes reflections on the drug development challenge based on the analysis of data from existing clinical trials.

General

Imprint: Imperial College Press
Country of origin: United Kingdom
Series: Molecular Medicine And Medicinal Chemistry, 5
Release date: March 2012
First published: November 2011
Authors: Natasha Kyprianou
Dimensions: 230 x 155 x 18mm (L x W x T)
Format: Hardcover
Pages: 232
Edition: New
ISBN-13: 978-1-84816-449-9
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-84816-449-1
Barcode: 9781848164499

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners